Antiviral compositions and method of use

Details Antiviral compositions and method of use Antiviral compositions and method of use

1994-10-03

1996-07-02

Schain, Howard E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 12, 514886, 514887, 530395, 424 7807, 424 9464, 435 692, 435236, A61K 3816, A61K 3848

Patent

active

055322158

ABSTRACT:
The present invention provides a method for inhibiting viral proliferation by preventing or inhibiting viral replication or killing the viruses on contact. Viral replication is prevented or inhibited through the use of serine protease inhibitors, their analogs, salts, conjugates or derivatives.

REFERENCES:
patent: 4829052 (1989-05-01), Glover et al.
patent: 4891356 (1990-01-01), Szabo
patent: 4916117 (1990-04-01), Lezdey et al.
patent: 5134119 (1992-06-01), Lezdey et al.
patent: 5151509 (1992-09-01), Kotowal et al.
patent: 5290762 (1994-03-01), Lezdey et al.
Ebina et al, Microbiol. Immunol., vol. 35, No. 7, pp. 583-588, 1991.
Korant et al, Biol. Chem. & Hopper-Syler, vol. 369, Supp. pp. 281-286, May 1988.
Weber et al, Science, vol. 243, pp. 928-931, 17 Feb. 1989.
McNeeley et al, "Secretory Leukocyte Protease Inhibitor: A Human Saliva Protein Exhibiting Anti-Human Immunodeficiency Virus 1 Activity In Vitro" The Journal of Clinical Investigation, vo. '96, Jul. 1995, 456-464.

Affiliated with

Also associated with

Rating

Antiviral compositions and method of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antiviral compositions and method of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiviral compositions and method of use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1506413